HeartDrug Research Laboratories

HeartDrug Research Laboratories is a cardiovascular research and consulting firm based in Towson, Maryland, led by Dr. Victor Serebruany. The laboratory is a prominent center for the study of platelet function and the evaluation of antiplatelet therapies, including clopidogrel, prasugrel, and ticagrelor. HeartDrug Research provides specialized services in clinical trial data analysis, post-marketing drug safety evaluation, and independent research on thrombosis and hemostasis. The entity has been notably involved in the critical assessment of major cardiovascular trials and holds intellectual property related to the treatment of arrhythmias and heart failure. It maintains a close research affiliation with Johns Hopkins University and has collaborated with numerous global pharmaceutical companies to evaluate drug efficacy and safety.